Hairy Cell Leukemia and Allied Chronic Lymphoid Leukemias: Current Knowledge and New Therapeutic Options

References

• Bouroncle B. A., Wiseman B. K., Doan C. A. Leukemic reticuloendotheliosis. Blood 1958; 13: 609–630
   PubMed Web of Science ®Google Scholar
• Schrek R., Donnely W. J. “Hairy Cells” in blood in lymphoreticular neoplastic disease and “flagellated” cells of normal lymph nodes. Blood 1966; 27: 199–211
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A. Leukemic reticuloendotheliosis (Hairy Cell Leukemia). Blood 1979; 53: 412–436
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Brayland R., Polliack A. “Hairy Cell” Leukemia. A scanning electron microscopic study of 8 cases. Brit. J. Haematology 1975; 29: 455–460
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Catovsky D., Golde D. W. Hairy Cell Leukemia. A clinical review based on 71 cases. Annals Internal Medicine 1978; 89: 677–683
   PubMed Web of Science ®Google Scholar
• Catovsky D. Hairy Cell Leukemia and Prolymphocytic Leukemia. Clinics of Hematology 1977; 6: 245–268
   PubMedGoogle Scholar
• Flandrin G., Daniel M. T. Hairy, Cell Leukemia. Cytochemistry and ultrastructure in diagnosis in human leukemias, A. Polliack. Martinus Nijhoff Pub. Klawer, BostonUSA 1984; 331–338
   Google Scholar
• Yam L. T., Li C. Y., Lam K. W. Tartrate resistant acid phosphatase isoenzyme in leukemic reticuloendotheliosis. New England J. Medicine 1971; 284: 360–357
   PubMed Web of Science ®Google Scholar
• Katayama I., Li C. Y., Yam L. T. Histochemical study of acid phosphatase isoewyme in leukemic reticuloendotheliosis. Cancer 1972; 29: 157–164
   PubMed Web of Science ®Google Scholar
• Katayama I., Schneider G. B. Further ultra-structural characterization of hairy cells of leukemic reticuloendotheliosis. American Journal of Pathology 1977; 86: 163–174
   PubMed Web of Science ®Google Scholar
• Bouroncle B. A. Unusual presentations and complications of hairy cell leukemia. Leukemia 1987; 1: 288–293
   PubMed Web of Science ®Google Scholar
• Nanba K., Soban E. J., Bowling M. C., Berard C. W. Splenic pseudosinuses and hepatic angiomatous lesions. Distinctive features of hairy cell leukemia. Am. J. Clin. Pathol. 1977; 67: 415–426
   PubMed Web of Science ®Google Scholar
• Foroni L., Catovsky D., Luzzatto L. Immunoglobulin gene rearrangements in hairy cell leukemia and other chronic B cell lymphoproliferative disorders. Leukemia 1987; 4: 389–392
   Google Scholar
• Korsmayer S. J., Green W. C., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakshsi A., Depper J. M., Leonard W. J., Jaffe E. S., Waldmdnn T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. USA 1983; 80: 4522–4526
   PubMed Web of Science ®Google Scholar
• Erber W. N., Phil D., Mason D. Y. Expression of the interleukin-2-receptor (Tac antigen/CD25) in hematologic neoplasms. Am. J. Clin. Pathol. 1988; 89: 645–648
   PubMed Web of Science ®Google Scholar
• Falini B., Pulford K., Erber W. N., Posnett D. N., Pallesen G., Schwrating R., Annino L., Caffolla A., Canino S., Mori A., Minelli O., Ciani C., Voxes E. E., Golomb H. M., Delsol G., Stein H., Martelli M. F., Grignan F., Mason D. Y. Use of a panel of monoclonal antibodies for the diagnosih of hairy cell leukemia. An immunocytochemical study of 136 cases. Histopthology 1986; 10: 671–687
   PubMed Web of Science ®Google Scholar
• Posnett D. N., Chiorazzi N., Kunkel H. G. Monoclonal antibodies with specificity for hairy cell leukemia cells. J. Clin. Invest 1982; 70: 34–261
   Google Scholar
• Vatdiman J. W., Gilewski T. A., Ratain M. J., Bitter M. A., Bradlow B. A., Golomb H. M. Evaluation of Leu-M5 (CDIIc) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am. J. Clin. Pathol. 1988; 90: 250–256
   PubMed Web of Science ®Google Scholar
• Barak V., Nisman B., Kalickman I., Dann E., Polliack A. Elevated serum IL-l levels in Hairy Cell Leukemia and correlation with disease activity. Blood 1992; 80(10)212, Supplement, (abstract)
   Google Scholar
• Lindemann A., Ludwig W. D., Oster W., Mertelsmann R., Hermann F. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 1981; 73: 880–884
   Google Scholar
• Lauria F., Raspadori D., Benfenati D., Rondelli D., Pallotti A., Tura S. Biological markers and minimal residual disease in hairy cell leukemia. Leukemia 1992; 6: 149–151
   PubMed Web of Science ®Google Scholar
• Flandrin G., Sigaux F., Sebanoun G., Bouffette P. Hairy cell leukemia: clinical presentation and follow-up of 211 patients. Semin. Oncol. 1984; 11(Suppl. 2)458–471
   PubMed Web of Science ®Google Scholar
• Quesada J. R., Reuben J., Manning J. T., Hersh E. M., Gutterman J. U. Alpha interferon for from induction of remission in hairy cell leukemia. N. Engl. J. Med. 1984; 310: 15–18
   PubMed Web of Science ®Google Scholar
• Janaen J., Hermans J. Splenectomy in hairy cell leukemia. A retrospective multicenter analysis. Cancer 1981; 47: 2066–2070
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Jacobh A., Feffer A., Oker H., Thompson J., Portlock C., Ratain M., Goldex D., Val-Diman J., Burke J. S., Brady J., Borunen E., Spiegel R. Alpha-2 interferon therapy of hairy-cell leukcinin: A Imtllticenler stucly of 64 patients. J. Clin. Oncol. 1986; 4: 900–905
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Ratain M. J., Fefer A., Thompson J., Golde D. W., Ozer H., Portlock C., Silber R., Rappeport J., Bonnen E., Spiegel K., Tensen L., Burke J. S., Vardiman J. W. Randomized study of the cluration of treatinent with interferon alpha-2b in patients with hairy cell leukemia. J. Natl. Cancer Inst. 1988; 80: 360–172
   Web of Science ®Google Scholar
• Moormeier J. A., Ratain M. J., Westbrook C. A. Vardlman, in hairy cell leukemia. Leukmia, 5: 602–604
   PubMedGoogle Scholar
• A single cycle of 2-chlorodeouyudenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 1992; 80: 2203–2209
   PubMed Web of Science ®Google Scholar
• Estey E. H., Kurzrock R., Kantarjian M., O'Brien S. M., McCredie K. B., Beran M., Koller C., Keating M. J., Hirsch-Ginsberg C., Huh Y. O., Stass S., Freireich E. J. Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 1992; 79: 882–887
   PubMed Web of Science ®Google Scholar
• Juliusson G., Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′deoxyadenosine (CdA): Relation to opportunistic infections. Blood 1902; 79: 888–894
   Google Scholar
• Juliusson G., Liliemark J., Hippe E., Blichfeldt P., Walman K., Hagberg H., Stolt C. M., Bergheim J. L., Winquist I., Hedenus M., Carlsson M., Velin L., Hellquist L., Kristofferson R., Ly B. E., Vaart J. Subcutaneous injections of 2-chloro-I'deoxyadenosine (CdA) as treatment for symptomatic hairy cell leukemia (HCL). (Abstract). Blood 1992; 80(Suppl. 10)1427
   Google Scholar
• Liliemark J., Albertioni F., Hassan M., Juliusson G. On the bioavailahility of oral and subcutaneous 2′-chloro-'deoxyadenosine in humans: alternative routes of administration. J Clin Oncol. 1992; 10: 1514–1518
   PubMed Web of Science ®Google Scholar
• Mintz U., Golomb H. M. Splenectomy as initial therapy in 26 patients with hairy cell leukemia. Cancer Research 1979; 39: 2366–2370
   PubMed Web of Science ®Google Scholar
• Saven A., Piro L. D. 2-CdA in the treatment of Hairy Cell Leukemia and Chronic Lymphocytic Leukemia. Leukemia and Lymphoma 1993; 11(Supp 2)109–114
   PubMed Web of Science ®Google Scholar
• Saven A., Piro L. D. Treatment of Hairy Cell Leukemia. Blood 1992; 79: 1111–1120
   PubMed Web of Science ®Google Scholar
• Robbins B. A., Ellison D. J., Spinosa J. C., Carry C. A., Lukec R. J., Poppema S., Saven A., Piro L. D. Diagnostic application of 2-color flow cytometry in 161 cases of hairy cell leukemia. Blood 1993; 82: 1277–1287
   PubMed Web of Science ®Google Scholar
• Cheaon B. D. Purine analogs in lymphoproliferative disorders. Leukemia and Lymphoma 1993; II(Suppl 2)153–160
   Google Scholar
• Pangalis G. A., Boussiotis V. A., Kittas C., Panayiotidis P. A., Loukopoulus D., Fessas P. Hairy cell leukemia: Splenectomy after alpha 2b-interferon therapy. Blood 1991; 78: 1385
   PubMed Web of Science ®Google Scholar
• Thaler J., Grünewald K., Gattringer C., Ho A. D., Weyrer K., Dieze O., Stauder R., Fluckinger T., Lang A., Huber H. Long term follow-up of patients with hairy cell leukemia treated with pentostain. Lymphocytic subpopulations and residual bone marrow infiltration. British Journal of Haematology 1993; 84: 75–82
   PubMed Web of Science ®Google Scholar
• Hakimian D., Tallman M. S., Kiley C., Peterson L. Detection of minimal residual disease by immunos-Paining of bone marrow biopsies after 2-CdA for hairy cell leukemia. Blood 1993; 82: 1798–1802
   PubMed Web of Science ®Google Scholar
• Beutler E., Piro L. D., Saven A., Kay A. C., et al. 2-CdA: A potent chemotherapeutic and immunosuppressive nucleoside. Leukemia and Lymphoma 1991; 5: 1–10
   PubMed Web of Science ®Google Scholar
• Ratain M., Golomb H. M., Vardiman J. W., Westbrook C. A., Barker C., Hooberman A., Bitter M. A., Daly K. Relapse after interferon alfa-2B therapy for Hairy Cell Leukemia. Analysis of prognostic variables. J. Clinical Oncology 1988; 6: 1714
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., et al. Proposals for the classification of chronic (mature) B and T lymphoid leukeias. J. Clinical Pathology 1989; 42: 567–584
   PubMed Web of Science ®Google Scholar
• Galton D. A. G., Goldman J. M., Wiltshaw J. M., et al. Prolymphocytic Leukemia. British Journal of Haematology 1974; 27: 7–23
   PubMed Web of Science ®Google Scholar
• Cawley J. C., Burns G. F., Hayhoe R. G. H. A chronic lymphoproliferative disorder with distinctive features: a distinct variant of hairy cell leukemia. Leukemia Research 1980; 4: 547–559
   PubMed Web of Science ®Google Scholar
• Catovsky D., O'Brien M., Melo J. V., et al. Hairy Cell Leukemia (HCL) variant. An intermediate disease between HCL and B-prolymphocytic leukemia. Seminars Oncology 1984; 11: 362–369
   PubMed Web of Science ®Google Scholar
• Melo J. V., Hedge U., Parreira A., et al. Splenic B-cell lymphoma with circulating villous lymphocytes: differential diagnosis of B-cell leukemias with large spleens. J. Clinical Pathology 1987; 40: 642–651
   PubMed Web of Science ®Google Scholar
• Neiman R. S., Sullivan A. L., Jaffe R. Malignant lymphoma simulating leukemic reticuloendothelio a clinicopathologic study of 10 cases. Cancer 1979; 43: 329–342
   PubMed Web of Science ®Google Scholar
• Jaffe S., Bookman M. A., Longo D. L. Lymphocytic lymphoma of intermediate differentiation. Mantle zone lymphoma: a distinct subtype of B-cell lymphoma. Human Pathology 1987; 18: 877–880
   PubMed Web of Science ®Google Scholar
• Mulligan S. P., Catovsky D. Splenic lymphoma with villous lymphocytes. Leukemia & Lymphoma 1992; 6: 97–106
   Web of Science ®Google Scholar
• Sainati L., Matutes E., Mulligan S., et al. A variant form of hairy cell leukemia resistant to interferon. Blood 1990; 76: 157–162
   PubMed Web of Science ®Google Scholar